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Previously, our lab has developed FRET-based cGMP-indi-
cators (cygnets) to study the spatial and temporal dynam-
ics of intracellular cGMP [1]. Cygnets have been proven to
advance our understanding of NO/cGMP signaling in vas-
cular smooth muscle cells [2]. However, FRET based indi-
cators suffer from intrinsic technical difficulties: they
require a dual emission detection system, show overall
low cyan/yellow emission ratio changes, and are generally
insensitive to physiological (low nanomolar) stimuli of
NO. These restrictions prompted us to develop several
novel, non-FRET based cGMP biosensors (FlincG:fluores-
cence indicator of cyclic GMP), which are composed of a
single circular permutated EGFP (cpEGFP) fused to regu-
latory fragments of cGMP-dependent protein kinase
(PKG). Based on the different PKG type I isoforms, we
designed α-FlincG and β-FlincG. A third construct (δ-
FlincG), had the entire N-terminal region truncated. All
three indicators were expressed and purified from E. coli
and showed cGMP selective changes in total 510 nm
emission intensities of 50–200% with apparent KD,cGMP
values ranging from 40 nM to 1.2 μM. Furthermore, we
observed a >1000 fold selectivity for cGMP over cAMP.
Interestingly, in adenovirus transfected vascular smooth
muscle cells (P0), FlincG indicators detected cGMP
responses to sub-nanomolar NO. The apparent EC50 val-
ues were determined as 0.3 nM, 12 nM and 7 nM for α-
FlincG, β-FlincG and δ-FlincG, respectively. Due to their
superior kinetic characteristics, FlincG biosensors may
serve as ideal tools to elucidate cGMP signaling in cul-
tured smooth muscle cells and in intact arteries using con-
ventional epi-fluorescence microscopy as well as confocal
fluorescence microscopy.
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